Background Specific morphologic features of hepatocellular carcinoma (HCC) on imaging have identifiable pathologic correlates as well as implications for altering surgical management and defining prognosis. In this study, we compared susceptibility-weighted imaging (SWI) to conventional techniques and correlated our findings with histopathology to determine the role of SWI in assessing morphologic features of HCC without using a contrast agent. Methods 86 consecutive patients with suspected HCC were imaged with MRI (including T1, T2, T2*, and SWI) and subsequently CT. 59 histologically-proven HCC lesions were identified in 53 patients. Each lesion on each imaging sequence was evaluated by two radiologists, and classified with respect to lesion morphology, signal intensity relative to surrounding hepatic parenchyma, presence of a pseudocapsule, presence of venous invasion, and internal homogeneity. Results Histopathology confirmed pseudocapsules in 41/59 lesions. SWI was able to detect a pseudocapsule in 34/41 lesions; compared to conventional T1/T2 imaging (12/41) and T2* (27/41). Mosaic pattern was identified in 25/59 lesions by histopathology; SWI confirmed this in all 25 lesions, compared to T1/T2 imaging (13/25) or T2* (18/25). Hemorrhage was confirmed by histopathology in 43/59 lesions, and visible on SWI in 41/43 lesions, compared to T1/T2 (7/43) and T2* (38/43). Venous invasion was confirmed by histopathology in 31/59 patients; SWI demonstrated invasion in 28/31 patients, compared to T1/T2 (7/31) and T2* (24/31). Conclusions SWI is better at identifying certain morphologic features such as pseudocapsule and hemorrhage than conventional MRI without using a contrast agent in HCC patients.
References
[1]
Miller G, Schwartz LH, D’Angelica M (2007) The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am 16: 343–368 doi:10.1016/j.soc.2007.04.001.
[2]
Perazella MA (2008) Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf 3: 67–75. doi: 10.2174/157488608783333989
[3]
Kadoya M, Matsui O, Takashima T, Nonomura A (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183: 819–825.
[4]
Ito K (2006) Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Eur J Radiol 58: 186–199 doi:10.1016/j.ejrad.2005.11.039.
[5]
Choi BI, Takayasu K, Han MC (1993) Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings. AJR Am J Roentgenol 160: 1177–1187 doi:10.2214/ajr.160.6.8388618.
[6]
Nakashima T, Kojiro M (1986) Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 6: 259–266 doi:10.1055/s-2008-1040608.
[7]
Grazioli L, Olivetti L, Fugazzola C, Benetti A, Stanga C, et al. (1999) The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 9: 62–67. doi: 10.1007/s003300050629
[8]
Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD (1996) Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20: 337–342. doi: 10.1097/00004728-199605000-00001
[9]
Honda H, Onitsuka H, Murakami J, Kaneko K, Murayama S, et al. (1992) Characteristic findings of hepatocellular carcinoma: an evaluation with comparative study of US, CT, and MRI. Gastrointest Radiol 17: 245–249. doi: 10.1007/bf01888559
[10]
Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, et al. (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15: 1375–1382 doi:10.1245/s10434-008-9846-9.
[11]
Beauchamp MH, Ditchfield M, Babl FE, Kean M, Catroppa C, et al. (2011) Detecting traumatic brain lesions in children: CT versus MRI versus susceptibility weighted imaging (SWI). J Neurotrauma 28: 915–927 doi:10.1089/neu.2010.1712.
[12]
Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, et al. (2005) Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging JMRI 22: 439–450 doi:10.1002/jmri.20404.
[13]
Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 30: 232–252 doi:10.3174/ajnr.A1461.
[14]
Mie MB, Nissen JC, Z？llner FG, Heilmann M, Schoenberg SO, et al. (2010) Susceptibility weighted imaging (SWI) of the kidney at 3T–initial results. Z Für Med Phys 20: 143–150 doi:10.1016/j.zemedi.2010.02.004.
[15]
Dai Y, Zeng M, Li R, Rao S, Chen C, et al. (2011) Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. J Magn Reson Imaging JMRI 34: 318–325 doi:10.1002/jmri.22607.
[16]
Chen W, DelProposto Z, Wu D, Wang J, Jiang Q, et al. (2012) Improved siderotic nodule detection in cirrhosis with susceptibility-weighted magnetic resonance imaging: a prospective study. PloS One 7: e36454 doi:10.1371/journal.pone.0036454.
[17]
Li R-K, Zeng M-S, Rao S-X, Qiang J-W, Dai Y-M, et al. (2012) Using a 2D multibreath-hold susceptibility-weighted imaging to visualize intratumoral hemorrhage of hepatocellular carcinoma at 3T MRI: correlation with pathology. J Magn Reson Imaging JMRI 36: 900–906 doi:10.1002/jmri.23734.
[18]
Chang S-X, Li G-W, Chen Y, Bao H, Zhou L, et al. (2013) Characterizing venous vasculatures of hepatocellular carcinoma using a multi-breath-hold two-dimensional susceptibility weighted imaging. PloS One 8: e65895 doi:10.1371/journal.pone.0065895.
[19]
Tao R, Zhang J, Dai Y, You Z, Fan Y, et al. (2012) Characterizing hepatocellular carcinoma using multi-breath-hold two-dimensional susceptibility-weighted imaging: comparison to conventional liver MRI. Clin Radiol 67: e91–97 doi:10.1016/j.crad.2012.08.015.
[20]
Choi JH, Kim JH, Won J-H, Kim YS, Goo DE, et al. (2004) Spontaneous intratumoral hemorrhage into hepatocellular carcinoma during transcatheter arterial embolization: a case report. J Korean Med Sci 19: 895–897. doi: 10.3346/jkms.2004.19.6.895
[21]
Onaya H, Itai Y (2000) MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 8: 757–768.
[22]
Hardie AD, Romano PB (2010) The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study. Magn Reson Imaging 28: 281–285 doi:10.1016/j.mri.2009.12.010.
[23]
Tan MGK, Kumarasinghe MP, Wang SM, Ooi LLPJ, Aw SE, et al. (2009) Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp Biol Med Maywood NJ 234: 693–702 doi:10.3181/0807-RM-227.
[24]
Lee JM, Yoon J-H, Kim KW (2012) Diagnosis of hepatocellular carcinoma: newer radiological tools. Semin Oncol 39: 399–409 doi:10.1053/j.seminoncol.2012.05.010.
[25]
Ebara M, Ohto M, Watanabe Y, Kimura K, Saisho H, et al. (1986) Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology 159: 371–377.
[26]
Earls JP, Theise ND, Weinreb JC, DeCorato DR, Krinsky GA, et al. (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201: 207–214 doi:10.1148/radiology.201.1.8816545.
